Matthew Korenberg Buys Shares of PVLA $PVLA
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Matthew Korenberg, CFO, Treasurer at Palvella Therapeutics, Inc. ($PVLA), bought 1,000 shares at an average price of $13.60, for a total transaction of $13,600. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Palvella Therapeutics, Inc. Stock Down 22.3%
Shares of Palvella Therapeutics, Inc. ($PVLA) traded around $116.51 on Tuesday, down 22.3% for the day.
Palvella Therapeutics, Inc. Earnings
Analysts Set New Price Targets
About Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.
Get Palvella Therapeutics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $PVLA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.